Stock listing
Supernus Pharmaceuticals, Inc.
Selected listing: SUPN · NASDAQ · USD · US
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), Health Technology. Latest release Aug 31, 2026: Chloe Kim Teams Up with Qelbree®, the 1 Prescribed Branded…
- Ticker
- NASDAQ:SUPN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a public company listed under the ticker SUPN, operating in the American market. Supernus focuses on developing and commercializing innovative therapies for central nervous system disorders.
Latest news from Supernus Pharmaceuticals, Inc.
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
August 31, 2026
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
August 7, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 3, 2026
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
July 22, 2026
Events
Research Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. company profile
View the public company page for Supernus Pharmaceuticals, Inc. on 6ix.
Supernus Pharmaceuticals, Inc. news
Read company news and market updates connected to Supernus Pharmaceuticals, Inc..
Supernus Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Supernus Pharmaceuticals, Inc..
Alternate listings
A1JX3U:LS
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
A1JX3U:LSX
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:GETTEX
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
SUPN:BOATS
US · USD
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
0LB2:LSE
GB · USD
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:FWB
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:BX
CH · CHF
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:DUS
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:MUN
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:SWB
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.
S49:TRADEGATE
DE · EUR
Alternate listing for Supernus Pharmaceuticals, Inc.; the primary context on this page is SUPN:NASDAQ.